HB263 — Cap cost sharing for prescription insulin drugs, diabetes devices

HB263 — Cap cost sharing for prescription insulin drugs, diabetes devices · Informed CitizenryHB263 enacts a new section of the Revised Code that establishes cost-sharing caps for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices. The bill defines these terms:…Open in Informed Citizenry